References
- Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095–128
- Rajaratnam JK, Marcus JR, Flaxman AD, et al. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970–2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet 2010;375:1988–2008
- Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:957–79
- Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence 2014;5:170–8
- Sharma D, Pandita A, Kumar C. Lactoferrin and neonates: role in prevention of neonatal sepsis and necrotizing enterocolitis. J Neonatal Biol 2014;3:1000E–110
- Sharma D, Murki A, Murki S, Pratap OT. Use of lactoferrin in the newborn: where do we stand? J Matern Fetal Neonatal Med 2014. [Epub ahead of print]
- Murki S, Jonnala S, Mohammed F, Reddy A. Restriction of cephalosporins and control of extended spectrum beta-lactamase producing gram negative bacteria in a neonatal intensive care unit. Indian Pediatr 2010;47:785–8
- Manzoni P, Decembrino L, Gallo E, et al. [Recent advances in prevention of sepsis in the preterm neonate]. Recenti Prog Med 2010;101:483–9
- Gathwala G, Sharma D, Bhakhri Bk. Effect of topical application of chlorhexidine for umbilical cord care in comparison with conventional dry cord care on the risk of neonatal sepsis: a randomized controlled trial. J Trop Pediatr 2013;59:209–13
- Sharma DK, Gathwala G, Shastri S. Chlorhexidine – a novel intervention to decrease the nursery stay and antibiotic exposure duration – randomized trial. J Matern Fetal Neonatal Med 2014. [Epub ahead of print]
- Sharma D, Gathwala G. Impact of chlorhexidine cleansing of the umbilical cord on cord separation time and neonatal mortality in comparison to dry cord care – a nursery-based randomized controlled trial. J Matern Fetal Neonatal Med 2014;27:1262–5
- Gupta B, Vaswani ND, Sharma D, et al. Evaluation of efficacy of skin cleansing with chlorhexidine in prevention of neonatal nosocomial sepsis – a randomised controlled trial. J Matern Fetal Neonatal Med 2014. [Epub ahead of print]
- Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285–91
- Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357–65
- Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001;20:1119–24
- Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660–6
- Uko S, Soghier LM, Vega M, et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 2006;117:1243–52
- Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007;356:2483–95
- Bertini G, Perugi S, Dani C, et al. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr 2005;147:162–5
- Parikh TB, Nanavati RN, Patankar CV, et al. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatr 2007;44:830–7
- National Neonatology Forum NNPD Network. National Neonatal Perinatal Database: report for 2002–2003. New Delhi: NNPD Network; 2005: 1–70
- David AK. Aiming for zero: preventing invasive Candida infections in extremely preterm infants. Neoreviews 2011;12:381–3
- Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 2008;121:703–10
- Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr 2005;147:166–71
- Kicklighter SD, Springer SC, Cox T, et al. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001;107:293–8
- Pinhat EC, Borba MGS, Ferreira ML, et al. Fungal colonization in newborn babies of very low birth weight: a cohort study. J Pediatr (Rio J) 2012;88:211–16
- Kaufman D, Boyle R, Hazen KC, et al. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr 2005;147:172–9
- Manzoni P, Farina D, Leonessa M, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006;118:2359–64